Status:
COMPLETED
Within-subject Variability of Insulin Detemir in Healthy Volunteers
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Healthy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This trial is conducted in Europe. The aim of this trial is to compare the within-subject variability of insulin detemir to that of another basal insulin analogue, insulin glargine in healthy voluntee...
Eligibility Criteria
Inclusion
- Healthy Japanese men or women
- Holding a Japanese pass-port and Japanese-born parents
- Considered generally healthy upon completion of medical history and physical examination as judged by the Investigator
- Body Mass Index (BMI) between 18 and 30 kg/m\^2, incl.
- Fasting blood glucose maximum 6 mmol/L
Exclusion
- Clinically significant abnormal haematology or biochemistry screening tests, as judged by the Investigator
- Any serious systemic infectious disease that occurred during the four weeks prior to the first dose of the trial product, as judged by the Investigator
- Subject with history of alcohol or drug dependence
Key Trial Info
Start Date :
May 27 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2004
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01497535
Start Date
May 27 2004
End Date
October 31 2004
Last Update
February 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Neuss, Germany, 41460